These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


228 related items for PubMed ID: 8444411

  • 1. Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial.
    Janssen HL, Berk L, Heijtink RA, ten Kate FJ, Schalm SW.
    Hepatology; 1993 Mar; 17(3):383-8. PubMed ID: 8444411
    [Abstract] [Full Text] [Related]

  • 2. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
    Zavaglia C, Bottelli R, Bellati G, Asti L, Mondazzi L, Iamoni G, Zanetti A, Tanzi E, Fesce E, Gelosa F, Maggi G, Ideo G.
    Ital J Gastroenterol; 1996 Mar; 28(6):324-31. PubMed ID: 8891847
    [Abstract] [Full Text] [Related]

  • 3. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E, Högemann B, Gerritzen A, Fischer HP, Wiese M, Kruis W, Malek M, Gugler R, Schmidt G, Huchzermeyer H, Gerlach U, Dengler HJ, Sauerbruch T.
    Hepatogastroenterology; 1998 Mar; 45(24):2282-94. PubMed ID: 9951911
    [Abstract] [Full Text] [Related]

  • 4. Therapy for chronic hepatitis B with lymphoblastoid interferon-alpha and levamisole.
    Fattovich G, Giustina G, Brollo L, Guido M, Pontisso P, Noventa F, Alberti A.
    Hepatology; 1992 Nov; 16(5):1115-9. PubMed ID: 1427652
    [Abstract] [Full Text] [Related]

  • 5. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK, Kumar M, Kumar R, Kazim SN, Guptan RC, Sakhuja P, Sharma BC.
    Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
    [Abstract] [Full Text] [Related]

  • 6. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
    Liu DL, Luo KX, Feng XR, Fu QX, Hou JL.
    Zhonghua Yi Xue Za Zhi; 2007 Jul 10; 87(26):1840-3. PubMed ID: 17922996
    [Abstract] [Full Text] [Related]

  • 7. [Alpha-interferon antiviral treatment in 100 patients with chronic hepatitis B].
    Janssen HL, Berk L, de Man RA, Heijtink RA, Schalm SW.
    Ned Tijdschr Geneeskd; 1992 Apr 25; 136(17):835-9. PubMed ID: 1522928
    [Abstract] [Full Text] [Related]

  • 8. Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: a multicenter controlled trial.
    Gregorio GV, Jara P, Hierro L, Diaz C, de la Vega A, Vegnente A, Iorio R, Bortolotti F, Crivellaro C, Zancan L, Daniels H, Portmann B, Mieli-Vergani G.
    Hepatology; 1996 Apr 25; 23(4):700-7. PubMed ID: 8666320
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial.
    Karabay O, Tamer A, Tahtaci M, Vardi S, Celebi H.
    J Microbiol Immunol Infect; 2005 Aug 25; 38(4):262-6. PubMed ID: 16118673
    [Abstract] [Full Text] [Related]

  • 10. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
    Yalçin K, Değertekin H, Kokoğlu OF, Ayaz C.
    Turk J Gastroenterol; 2004 Mar 25; 15(1):14-20. PubMed ID: 15264116
    [Abstract] [Full Text] [Related]

  • 11. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial.
    Chung YH, Song BC, Lee GC, Shin JW, Ryu SH, Jung SA, Yoo K, Lee HC, Lee YS, Suh DJ.
    Eur J Gastroenterol Hepatol; 2003 May 25; 15(5):489-93. PubMed ID: 12702905
    [Abstract] [Full Text] [Related]

  • 12. [Quantitative detection of intrahepatic hepatitis B virus DNA in patients with chronic hepatitis B].
    Lu H, Ma LX, Xu WS, Zhang HY, Yu LJ, Duan HY.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar 25; 11(3):173-5. PubMed ID: 12681068
    [Abstract] [Full Text] [Related]

  • 13. [Comparison of different combination therapies for children with HBeAg positive chronic hepatitis B].
    Zhong XH, Deng X, Chen XC, Zhou BP.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar 25; 21(1):62-3. PubMed ID: 17429539
    [Abstract] [Full Text] [Related]

  • 14. Multicenter retrospective study of response to interferon in chronic hepatitis B.
    Martín-Vivaldi R, Nogueras F, Vignote ML, Salmerón J, Aguilar J, Romero M, Andrade R, De la Mata M, Moreno JM, Pérez J, García G, López de Hierro M, Gómez F, Palacios A, Otero S, Suárez E, Poyatos A, Quintero D.
    Rev Esp Enferm Dig; 2000 Sep 25; 92(9):561-72. PubMed ID: 11138238
    [Abstract] [Full Text] [Related]

  • 15. Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers.
    Akhan SC, Yulugkural Z, Vahaboglu H.
    Chemotherapy; 2007 Sep 25; 53(6):402-6. PubMed ID: 17934260
    [Abstract] [Full Text] [Related]

  • 16. Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial.
    Sostegni R, Ghisetti V, Pittaluga F, Marchiaro G, Rocca G, Borghesio E, Rizzetto M, Saracco G.
    Hepatology; 1998 Aug 25; 28(2):341-6. PubMed ID: 9695995
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of viral replication in children with chronic hepatitis B with and without interferon treatment.
    Lazăr C, Grigorescu-Sido P, Manasia R, Mireştean S, Skorka C, Neculoiu D, Molnar G, Cocean S.
    Rom J Gastroenterol; 2005 Sep 25; 14(3):219-24. PubMed ID: 16200230
    [Abstract] [Full Text] [Related]

  • 18. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally.
    Zielińska W, Paszkiewicz J, Korczak A, Własiuk M, Zółtowska A, Szutowicz A, Cummins JM, Georgiades JA.
    Arch Immunol Ther Exp (Warsz); 1993 Sep 25; 41(3-4):241-51. PubMed ID: 8129568
    [Abstract] [Full Text] [Related]

  • 19. Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study.
    Serfaty L, Thabut D, Zoulim F, Andreani T, Chazouillères O, Carbonell N, Loria A, Poupon R.
    Hepatology; 2001 Sep 25; 34(3):573-7. PubMed ID: 11526544
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.
    Sakai T, Shiraki K, Inoue H, Okano H, Deguchi M, Sugimoto K, Ohmori S, Murata K, Nakano T.
    Int J Mol Med; 2002 Aug 25; 10(2):201-4. PubMed ID: 12119559
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.